Exosomal lncRNA ATB Derived from Ovarian Cancer Cells Promotes Angiogenesis via Regulating miR-204-3p/TGFβR2 Axis

References

• Webb PM, Jordan SJ. Epidemiology of epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 2017;41:3–14. doi:10.1016/j.bpobgyn.2016.08.006
   PubMed Web of Science ®Google Scholar
• Prat J, D’Angelo E, Espinosa I. Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics. Hum Pathol. 2018;80:11–27. doi:10.1016/j.humpath.2018.06.018
   PubMed Web of Science ®Google Scholar
• Veneris JT, Mahajan P, Frazier AL. Contemporary management of ovarian germ cell tumors and remaining controversies. Gynecol Oncol. 2020;158(2):467–475. doi:10.1016/j.ygyno.2020.05.007
   PubMed Web of Science ®Google Scholar
• Spanheimer PM, Murray MP, Zabor EC, et al. Long-term outcomes after surgical treatment of malignant/borderline phyllodes tumors of the breast. Ann Surg Oncol. 2019;26(7):2136–2143. doi:10.1245/s10434-019-07210-4
   PubMed Web of Science ®Google Scholar
• Roett MA, Evans P. Ovarian cancer: an overview. Am Fam Physician. 2009;80(6):609–616.
   PubMed Web of Science ®Google Scholar
• Guan LY, Lu Y. New developments in molecular targeted therapy of ovarian cancer. Discov Med. 2018;26(144):219–229.
   PubMed Web of Science ®Google Scholar
• Paleari L, DeCensi A. Endocrine therapy in ovarian cancer: where do we stand? Curr Opin Obstet Gynecol. 2018;30(1):17–22. doi:10.1097/GCO.0000000000000423
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhang L, Li F. Integrative network analysis identifies potential targets and drugs for ovarian cancer. BMC Med Genomics. 2020;13(Suppl 9):132. doi:10.1186/s12920-020-00773-2
   PubMed Web of Science ®Google Scholar
• Doubeni CA, Doubeni AR, Myers AE. Diagnosis and management of ovarian cancer. Am Fam Physician. 2016;93(11):937–944.
   PubMed Web of Science ®Google Scholar
• Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:6478. doi:10.1126/science.aau6977
   Web of Science ®Google Scholar
• Kalluri R. The biology and function of exosomes in cancer. J Clin Invest. 2016;126(4):1208–1215. doi:10.1172/JCI81135
   PubMed Web of Science ®Google Scholar
• Azmi AS, Bao B, Sarkar FH. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev. 2013;32(3–4):623–642. doi:10.1007/s10555-013-9441-9
   PubMed Web of Science ®Google Scholar
• Zhang L, Yu D. Exosomes in cancer development, metastasis, and immunity. Biochim Biophys Acta Rev Cancer. 2019;1871(2):455–468. doi:10.1016/j.bbcan.2019.04.004
   PubMed Web of Science ®Google Scholar
• Feng W, Dean DC, Hornicek FJ, Shi H, Duan Z. Exosomes promote pre-metastatic niche formation in ovarian cancer. Mol Cancer. 2019;18(1):124. doi:10.1186/s12943-019-1049-4
   PubMed Web of Science ®Google Scholar
• Arneth B. Tumor microenvironment. Medicina. 2019;56(1). doi:10.3390/medicina56010015
   PubMed Web of Science ®Google Scholar
• Cai H, Gong L, Liu J, Zhou Q, Zheng Z. Diosgenin inhibits tumor angiogenesis through regulating GRP78-mediated HIF-1α and VEGF/VEGFR signaling pathways. Die Pharmazie. 2019;74(11):680–684. doi:10.1691/ph.2019/9526
   PubMed Web of Science ®Google Scholar
• Zhang D, Ding L, Li Y, et al. Midkine derived from cancer-associated fibroblasts promotes cisplatin-resistance via up-regulation of the expression of lncRNA ANRIL in tumour cells. Sci Rep. 2017;7(1):16231. doi:10.1038/s41598-017-13431-y
   PubMed Web of Science ®Google Scholar
• Yuan D, Qian H, Guo T, et al. LncRNA-ATB promotes the tumorigenesis of ovarian cancer via targeting miR-204-3p. Onco Targets Ther. 2020;13:573–583. doi:10.2147/OTT.S230552
   PubMed Web of Science ®Google Scholar
• Chen X, Zhang S, Du K, et al. Gastric cancer-secreted exosomal X26nt increases angiogenesis and vascular permeability by targeting VE-cadherin. Cancer Sci. 2021;112(5):1839–1852. doi:10.1111/cas.14740
   PubMed Web of Science ®Google Scholar
• Hu J, Zhang L, Mei Z, et al. Interaction of E3 ubiquitin ligase MARCH7 with long noncoding RNA MALAT1 and autophagy-related protein ATG7 promotes autophagy and invasion in ovarian cancer. Cell Physiol Biochem. 2018;47(2):654–666. doi:10.1159/000490020
   PubMedGoogle Scholar
• Christie M, Oehler MK. Molecular pathology of epithelial ovarian cancer. J Br Menopause Soc. 2006;12(2):57–63. doi:10.1258/136218006777525794
   PubMedGoogle Scholar
• Abedini Bakhshmand E, Mohammad Soltani B, Fasihi A, Mowla SJ. Hsa-miR-5582-3P regulatory effect on TGFβ signaling through targeting of TGFβ-R1, TGFβ-R2, SMAD3, and SMAD4 transcripts. J Cell Biochem. 2018;119(12):9921–9930. doi:10.1002/jcb.27314
   PubMed Web of Science ®Google Scholar
• Sanada TJ, Sun XQ, Happé C, et al. Altered TGFβ/SMAD signaling in human and rat models of pulmonary hypertension: an old target needs attention. Cells. 2021;10:1. doi:10.3390/cells10010084
   Web of Science ®Google Scholar
• Odero-Marah V, Hawsawi O, Henderson V, Sweeney J. Epithelial-mesenchymal transition (EMT) and prostate cancer. Adv Exp Med Biol. 2018;1095:101–110.
   PubMed Web of Science ®Google Scholar
• Sun Z, Ettensohn CA. TGF-β sensu stricto signaling regulates skeletal morphogenesis in the sea urchin embryo. Dev Biol. 2017;421(2):149–160. doi:10.1016/j.ydbio.2016.12.007
   PubMed Web of Science ®Google Scholar
• Baig MS, Roy A, Rajpoot S, et al. Tumor-derived exosomes in the regulation of macrophage polarization. Inflamm Res. 2020;69(5):435–451. doi:10.1007/s00011-020-01318-0
   PubMed Web of Science ®Google Scholar
• Tang X, Liu S, Liu Y, et al. Circulating serum exosomal aHIF is a novel prognostic predictor for epithelial ovarian cancer. Onco Targets Ther. 2019;12:7699–7711. doi:10.2147/OTT.S220533
   PubMed Web of Science ®Google Scholar
• Kok VC, Yu CC. Cancer-derived exosomes: their role in cancer biology and biomarker development. Int J Nanomed. 2020;15:8019–8036. doi:10.2147/IJN.S272378
   PubMed Web of Science ®Google Scholar
• Yang C, Kim HS, Song G, Lim W. The potential role of exosomes derived from ovarian cancer cells for diagnostic and therapeutic approaches. J Cell Physiol. 2019;234(12):21493–21503. doi:10.1002/jcp.28905
   PubMed Web of Science ®Google Scholar
• Zhang H, Lu B. microRNAs as biomarkers of ovarian cancer. Expert Rev Anticancer Ther. 2020;20(5):373–385. doi:10.1080/14737140.2020.1760095
   PubMed Web of Science ®Google Scholar